RSS   Newsletter   Contact   Advertise with us
Post Online Media

Alphatec Spine appoints Jeffrey G. Black as CFO

Jeffrey G. BlackAlphatec Spine, a medical device company, announced the hiring of Jeffrey G. Black as executive vice president and chief financial officer.
Mr. Black is a seasoned executive with over 25 years of experience in financial and operations management, including senior-level finance roles for six publicly-traded companies.

Mr. Black previously served as the Chief Financial Officer of Applied Proteomics, Inc., a company that develops novel, non-invasive diagnostics using a proteomics-based platform.

Before joining Applied Proteomics, he served as the Chief Financial Officer of AltheaDx, Inc., a molecular diagnostics company specializing in pharmacogenetic testing.

Prior to AltheaDx, Mr. Black served as Chief Financial Officer of Verenium Corporation (formerly Diversa Corporation), a Nasdaq-listed pioneer in the development and commercialization of high-performance enzymes for use in industrial processes.

During his nine-year tenure at Verenium/Diversa, he played a leadership role in more than $500 million of strategic, equity, and debt financing transactions, culminating in the sale of the company to BASF in 2013.

Mr. Black is a certified public accountant (inactive) and began his career with Ernst & Young LLP.

He currently serves on the Board of Directors of Cellana, Inc., a privately-held algae bioproducts company.




We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy